Skip to main content
Top
Published in: Current Hypertension Reports 3/2013

01-06-2013 | Invited Commentary

High Blood Pressure: The Leading Global Burden of Disease Risk Factor and the Need for Worldwide Prevention Programs

Authors: Samantha Bromfield, Paul Muntner

Published in: Current Hypertension Reports | Issue 3/2013

Login to get access

Excerpt

It has been long recognized that hypertension is an important risk factor for cardiovascular disease and mortality [1]. Traditionally, a high burden of hypertension and its adverse consequences has been mistakenly thought to be an affliction of only economically developed countries [2]. However, studies over the past two decades have reported that the majority of people in many economically developing countries have blood pressure above the levels considered optimal, with a high prevalence of hypertension present [35]. Although a high prevalence of hypertension in all world regions has been previously reported, a recent publication from the Global Burden of Disease (GBD) Study has placed a renewed focus on the heavy toll high blood pressure is having in all regions of the world [6, 7]. …
Literature
1.
go back to reference Pickering GW. The natural history of hypertension. Br Med Bull. 1952;8(4):305–9.PubMed Pickering GW. The natural history of hypertension. Br Med Bull. 1952;8(4):305–9.PubMed
2.
go back to reference Pearson TA. Cardiovascular disease in developing countries: myths, realities, and opportunities. Cardiovasc Drugs Ther. 1999;13(2):95–104.PubMedCrossRef Pearson TA. Cardiovascular disease in developing countries: myths, realities, and opportunities. Cardiovasc Drugs Ther. 1999;13(2):95–104.PubMedCrossRef
3.
go back to reference Singh RB, Suh IL, Singh VP, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens. 2000;14(10–11):749–63. Singh RB, Suh IL, Singh VP, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens. 2000;14(10–11):749–63.
4.
go back to reference Hernández-Hernández R, Armas-Padilla MC, Armas-Hernández MJ, et al. Hypertension and cardiovascular health in Venezuela and Latin American countries. J Hum Hypertens. 2000;14 Suppl 1:S2–5.PubMedCrossRef Hernández-Hernández R, Armas-Padilla MC, Armas-Hernández MJ, et al. Hypertension and cardiovascular health in Venezuela and Latin American countries. J Hum Hypertens. 2000;14 Suppl 1:S2–5.PubMedCrossRef
5.
go back to reference Gupta R. Hypertension in India–definition, prevalence and evaluation. J Indian Med Assoc. 1999;97(3):74–80.PubMed Gupta R. Hypertension in India–definition, prevalence and evaluation. J Indian Med Assoc. 1999;97(3):74–80.PubMed
6.
go back to reference Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.
7.
go back to reference Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet. 2011;377(9765):568–77.PubMedCrossRef Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet. 2011;377(9765):568–77.PubMedCrossRef
8.
go back to reference Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349(9061):1269–76.PubMedCrossRef Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349(9061):1269–76.PubMedCrossRef
12.
go back to reference Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2224–60.CrossRef Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2224–60.CrossRef
13.
go back to reference Perkovic V, Huxley R, Wu Y, et al. The burden of blood pressure-related disease: a neglected priority for global health. Hypertension. 2007;50(6):991–7.PubMedCrossRef Perkovic V, Huxley R, Wu Y, et al. The burden of blood pressure-related disease: a neglected priority for global health. Hypertension. 2007;50(6):991–7.PubMedCrossRef
Metadata
Title
High Blood Pressure: The Leading Global Burden of Disease Risk Factor and the Need for Worldwide Prevention Programs
Authors
Samantha Bromfield
Paul Muntner
Publication date
01-06-2013
Publisher
Current Science Inc.
Published in
Current Hypertension Reports / Issue 3/2013
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-013-0340-9

Other articles of this Issue 3/2013

Current Hypertension Reports 3/2013 Go to the issue

Blood Pressure Monitoring and Management (J Redon, Section Editor)

Role of Ambulatory Blood Pressure Monitoring in Hypertension and Diabetes

Therapeutic Trials (G Mancia, Section Editor)

Heart Rate and the Cardiometabolic Risk

Therapeutic Trials (G Mancia, Section Editor)

Retinal Arterial Hypertrophy: the New LVH?

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.